Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Zoetis Inc.
Report date May 20, 2021 · Filed May 24, 2021
Section 16 reporting ended · disclosed 2021-05-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 215,129 |
Reported balance
After 2021-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-05-20 · Exercise / conversion · Acquired 130 · Balance 215,129 F1: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Alaix's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 29,086.0632 |
Reported balance
After 2021-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-05-20 · Exercise / conversion · Disposed 130.8769 · Balance 29,086.0632 F2: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F3: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F4: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F5: Not applicable. F6: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022; and 1,302.2257 RSUs will vest on February 10, 2024. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 27,783.8375 |
Reported balance
After 2021-05-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-05-20 · Disposition to issuer · Disposed 1,302.2257 · Balance 27,783.8375 F2: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F3: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F4: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F5: Not applicable. F7: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Alaix's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.
F2: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F3: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
F4: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F5: Not applicable.
F6: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022; and 1,302.2257 RSUs will vest on February 10, 2024.
F7: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2020 Filed Feb 19, 2020 22:18 UTC | Zoetis Inc. ZTS · Entity 679 | GrantDeferred Stock Unit · Derivative | 45,073.9908 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000115 · wf-form4_158215071065836.xml · derivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,705.2217 Underlying: Common Stock · 45,073.9908 shares Expires not disclosed F4 · security: Represents DSUs received pursuant to the Zoetis Equity Deferral Plan. DSUs are fully vested and are settled, together with dividend equivalent units automatically issued thereon, in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F5 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock in accordance with the terms of the Zoetis Equity Deferral Plan. F2 · price: Upon the vesting of the reporting person's restricted stock units on 2/14/2020, the reporting person received 45,073.9908 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F2 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on 2/14/2020, the reporting person received 45,073.9908 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F2 · derivative.expiration_date: Upon the vesting of the reporting person's restricted stock units on 2/14/2020, the reporting person received 45,073.9908 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 45,073.9908 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000115 · wf-form4_158215071065836.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,902.0496 Underlying: Common Stock · 45,073.9908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Vesting of restricted stock units ("RSUs") granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on 2/14/2020, the reporting person received 45,073.9908 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F2 · derivative.expiration_date: Upon the vesting of the reporting person's restricted stock units on 2/14/2020, the reporting person received 45,073.9908 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F3 · balance_after: The RSUs vest as follows: 37,316.1003 RSUs will vest on February 13, 2021; and 27,585.9493 RSUs will vest on February 12, 2022. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:19 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPerformance Award Unit · Derivative | 66,772.2058 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000066 · wf-form4_158163233553269.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,772.2058 Underlying: Common Stock · 66,772.2058 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2017-2019 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 11, 2020, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 14, 2020, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 14, 2020, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 22:02 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 382.0695 | $42.28 | $16,153.90 |
DisclosureSEC source: 0001555280-20-000015 · wf-form4_157903930749846.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,275.2678 Underlying: Common Stock · 119.1554 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 21:46 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000280 · wf-form4_157428637962190.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 711,046 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F3 · derivative.exercise_price: 50,000 options granted February 27, 2015 at an exercise price of $46.09 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 109,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 21:46 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 50,000 | $119.13 | $5,956,500.00 |
DisclosureSEC source: 0001555280-19-000280 · wf-form4_157428637962190.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.80 to $119.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 21:46 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 50,000 | $46.09 | $2,304,500.00 |
DisclosureSEC source: 0001555280-19-000280 · wf-form4_157428637962190.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 20:30 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 345.2057 | $40.11 | $13,846.20 |
DisclosureSEC source: 0001555280-19-000255 · wf-form4_157117137693246.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,893.1983 Underlying: Common Stock · 107.7777 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 19, 2019 Filed Jul 23, 2019 20:30 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 450.9724 | $35.82 | $16,153.83 |
DisclosureSEC source: 0001555280-19-000214 · wf-form4_156391382098464.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,547.9926 Underlying: Common Stock · 141.5885 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| April 12, 2019 Filed Apr 16, 2019 20:48 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 3,194.4109 | $32.00 | $102,221.15 |
DisclosureSEC source: 0001555280-19-000152 · wf-form4_155544768288794.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,097.0202 Underlying: Common Stock · 1,005.421 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 27, 2019 Filed Mar 29, 2019 20:29 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 4,748.8735 | $31.06 | $147,500.01 |
DisclosureSEC source: 0001555280-19-000134 · wf-form4_155389136841852.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,902.6093 Underlying: Common Stock · 1,497.158 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 21:37 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 178,587 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000109 · wf-form4_155147624339511.xml · derivative · entry 6 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761,046 Underlying: Common Stock · 178,587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F8 · derivative.exercise_price: 178,587 options granted March 4, 2014 at an exercise price of $30.89 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 21:37 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 178,587 | $94.19 | $16,821,109.53 |
DisclosureSEC source: 0001555280-19-000109 · wf-form4_155147624339511.xml · nonDerivative · entry 4 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.86 to $94.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 21:37 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 178,587 | $30.89 | $5,516,552.43 |
DisclosureSEC source: 0001555280-19-000109 · wf-form4_155147624339511.xml · nonDerivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 21:37 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 133,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000109 · wf-form4_155147624339511.xml · derivative · entry 5 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 939,633 Underlying: Common Stock · 133,522 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 133,522 options granted March 4, 2014 at an exercise price of $30.89 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 178,587 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 21:37 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 133,522 | $93.89 | $12,536,380.58 |
DisclosureSEC source: 0001555280-19-000109 · wf-form4_155147624339511.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.67 to $94.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 21:37 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 133,522 | $30.89 | $4,124,494.58 |
DisclosureSEC source: 0001555280-19-000109 · wf-form4_155147624339511.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:02 UTC | Zoetis Inc. ZTS · Entity 679 | GrantDeferred Stock Unit · Derivative | 85,442.4512 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-19-000098 · wf-form4_155078651364297.xml · derivative · entry 4 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,227.2761 Underlying: Common Stock · 85,442.4512 shares Expires not disclosed F4 · security: Represents DSUs received pursuant to the Zoetis Equity Deferral Plan. DSUs are fully vested and are settled, together with dividend equivalent units automatically issued thereon, in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F5 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock in accordance with the terms of the Zoetis Equity Deferral Plan. F7 · price: Upon the vesting of the reporting person's performance award units on 2/19/2019, the reporting person received 85,442.4512 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F7 · derivative.exercise_date: Upon the vesting of the reporting person's performance award units on 2/19/2019, the reporting person received 85,442.4512 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F7 · derivative.expiration_date: Upon the vesting of the reporting person's performance award units on 2/19/2019, the reporting person received 85,442.4512 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:02 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 85,442.4512 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000098 · wf-form4_155078651364297.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 85,442.4512 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Vesting of performance award units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F7 · derivative.exercise_date: Upon the vesting of the reporting person's performance award units on 2/19/2019, the reporting person received 85,442.4512 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F7 · derivative.expiration_date: Upon the vesting of the reporting person's performance award units on 2/19/2019, the reporting person received 85,442.4512 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:02 UTC | Zoetis Inc. ZTS · Entity 679 | GrantDeferred Stock Unit · Derivative | 51,270.1685 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-19-000098 · wf-form4_155078651364297.xml · derivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,784.8249 Underlying: Common Stock · 51,270.1685 shares Expires not disclosed F4 · security: Represents DSUs received pursuant to the Zoetis Equity Deferral Plan. DSUs are fully vested and are settled, together with dividend equivalent units automatically issued thereon, in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F5 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock in accordance with the terms of the Zoetis Equity Deferral Plan. F2 · price: Upon the vesting of the reporting person's restricted stock units on 2/19/2019, the reporting person received 51,270.1685 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F2 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on 2/19/2019, the reporting person received 51,270.1685 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F2 · derivative.expiration_date: Upon the vesting of the reporting person's restricted stock units on 2/19/2019, the reporting person received 51,270.1685 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:02 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 51,270.1685 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000098 · wf-form4_155078651364297.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,334.3889 Underlying: Common Stock · 51,270.1685 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Vesting of restricted stock units ("RSUs") granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on 2/19/2019, the reporting person received 51,270.1685 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F2 · derivative.expiration_date: Upon the vesting of the reporting person's restricted stock units on 2/19/2019, the reporting person received 51,270.1685 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F3 · balance_after: The RSUs vest as follows: 44,811.0081 RSUs will vest on February 14, 2020; 37,098.3808 RSUs will vest on February 13, 2021; and 27,425.0000 RSUs will vest on February 12, 2022. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:22 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPerformance Award Unit · Derivative | 85,442.4512 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000061 · wf-form4_155019012085567.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,442.4512 Underlying: Common Stock · 85,442.4512 shares Expires not disclosed F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:22 UTC | Zoetis Inc. ZTS · Entity 679 | GrantStock Option · Derivative | 110,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000061 · wf-form4_155019012085567.xml · derivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,073,155 Underlying: Common Stock · 110,192 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:22 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 27,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000061 · wf-form4_155019012085567.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,604.5574 Underlying: Common Stock · 27,425 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 51,270.1685 RSUs will vest on February 19, 2019; 44,811.0081 RSUs will vest on February 14, 2020; 37,098.3808 RSUs will vest on February 13, 2021; and 27,425.0000 RSUs will vest on February 12, 2022. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:51 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 592.8011 | $27.25 | $16,153.83 |
DisclosureSEC source: 0001555280-19-000015 · wf-form4_154758905622095.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,153.7358 Underlying: Common Stock · 187.7043 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 150,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-18-000271 · wf-form4_154179854214205.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 962,963 Underlying: Common Stock · 150,306 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F3 · derivative.exercise_price: 150,306 options granted January 31, 2013 at an exercise price of $26.00 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; and 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 150,306 | $94.96 | $14,273,057.76 |
DisclosureSEC source: 0001555280-18-000271 · wf-form4_154179854214205.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.54 to $95.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 150,306 | $26.00 | $3,907,956.00 |
DisclosureSEC source: 0001555280-18-000271 · wf-form4_154179854214205.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 21:00 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 493.6235 | $28.05 | $13,846.14 |
DisclosureSEC source: 0001555280-18-000265 · wf-form4_153972360163706.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,560.9347 Underlying: Common Stock · 155.7496 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 20:23 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 135,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-18-000232 · wf-form4_153436461440687.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,113,269 Underlying: Common Stock · 135,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F3 · derivative.exercise_price: 135,000 options granted January 31, 2013 at an exercise price of $26.00 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 150,306 options granted January 31, 2013 at an exercise price of $26.00 per option; 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; and 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 20:23 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 135,000 | $91.55 | $12,359,250.00 |
DisclosureSEC source: 0001555280-18-000232 · wf-form4_153436461440687.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.27 to $91.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 20:23 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 135,000 | $26.00 | $3,510,000.00 |
DisclosureSEC source: 0001555280-18-000232 · wf-form4_153436461440687.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2018 Filed Jul 17, 2018 20:57 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 594.3278 | $27.18 | $16,153.83 |
DisclosureSEC source: 0001555280-18-000207 · wf-form4_153186100926963.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,067.3112 Underlying: Common Stock · 187.53 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 20:55 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 3,323.0709 | $26.36 | $87,596.15 |
DisclosureSEC source: 0001555280-18-000158 · wf-form4_152399849656984.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,472.9834 Underlying: Common Stock · 1,048.177 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 21:49 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 4,376.4284 | $26.59 | $116,369.23 |
DisclosureSEC source: 0001555280-18-000136 · wf-form4_152115052843244.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,149.9125 Underlying: Common Stock · 1,379.5996 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:06 UTC | Zoetis Inc. ZTS · Entity 679 | GrantDeferred Stock Unit · Derivative | 60,457.6202 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-18-000108 · wf-form4_151994198054961.xml · derivative · entry 4 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,869.7507 Underlying: Common Stock · 60,457.6202 shares Expires not disclosed F4 · security: Represents DSUs received pursuant to the Zoetis Equity Deferral Plan. DSUs are fully vested and are settled, together with dividend equivalent units automatically issued thereon, in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F5 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock in accordance with the terms of the Zoetis Equity Deferral Plan. F7 · price: Upon the vesting of the reporting person's performance award units on 2/27/2018, the reporting person received 60,457.6202 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F7 · derivative.exercise_date: Upon the vesting of the reporting person's performance award units on 2/27/2018, the reporting person received 60,457.6202 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F7 · derivative.expiration_date: Upon the vesting of the reporting person's performance award units on 2/27/2018, the reporting person received 60,457.6202 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:06 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 60,457.6202 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-18-000108 · wf-form4_151994198054961.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,457.6202 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Vesting of performance award units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F7 · derivative.exercise_date: Upon the vesting of the reporting person's performance award units on 2/27/2018, the reporting person received 60,457.6202 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F7 · derivative.expiration_date: Upon the vesting of the reporting person's performance award units on 2/27/2018, the reporting person received 60,457.6202 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:06 UTC | Zoetis Inc. ZTS · Entity 679 | GrantDeferred Stock Unit · Derivative | 41,412.1305 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-18-000108 · wf-form4_151994198054961.xml · derivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,412.1305 Underlying: Common Stock · 41,412.1305 shares Expires not disclosed F4 · security: Represents DSUs received pursuant to the Zoetis Equity Deferral Plan. DSUs are fully vested and are settled, together with dividend equivalent units automatically issued thereon, in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F5 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock in accordance with the terms of the Zoetis Equity Deferral Plan. F2 · price: Upon the vesting of the reporting person's restricted stock units on 2/27/2018, the reporting person received 41,412.1305 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F2 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on 2/27/2018, the reporting person received 41,412.1305 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F2 · derivative.expiration_date: Upon the vesting of the reporting person's restricted stock units on 2/27/2018, the reporting person received 41,412.1305 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:06 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 41,412.1305 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-18-000108 · wf-form4_151994198054961.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,341.7432 Underlying: Common Stock · 41,412.1305 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Vesting of restricted stock units ("RSUs") granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · derivative.exercise_date: Upon the vesting of the reporting person's restricted stock units on 2/27/2018, the reporting person received 41,412.1305 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F2 · derivative.expiration_date: Upon the vesting of the reporting person's restricted stock units on 2/27/2018, the reporting person received 41,412.1305 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F3 · balance_after: The RSUs vest as follows: 50,947.6349 RSUs will vest on February 19, 2019; 44,529.1083 RSUs will vest on February 14, 2020; and 36,865 RSUs will vest on February 13, 2021. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:32 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPerformance Award Unit · Derivative | 60,457.6202 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-18-000055 · wf-form4_151873030445103.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,457.6202 Underlying: Common Stock · 60,457.6202 shares Expires not disclosed F10 · security: Represents performance award units with a three-year performance period covering 2015-2017 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 13, 2018, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:32 UTC | Zoetis Inc. ZTS · Entity 679 | GrantStock Option · Derivative | 133,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-18-000055 · wf-form4_151873030445103.xml · derivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,248,269 Underlying: Common Stock · 133,070 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 285,306 options granted January 31, 2013 at an exercise price of $26.00 per option; 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; and 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 285,306 options granted January 31, 2013 at an exercise price of $26.00 per option; 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; and 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:32 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 36,865 | $73.24 | $2,699,992.60 |
DisclosureSEC source: 0001555280-18-000055 · wf-form4_151873030445103.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,753.8737 Underlying: Common Stock · 36,865 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 41,412.1305 RSUs will vest on February 27, 2018; 50,947.6349 RSUs will vest on February 19, 2019; 44,529.1083 RSUs will vest on February 14, 2020; and 36,865 RSUs will vest on February 13, 2021. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 22:04 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 675.8925 | $23.90 | $16,153.83 |
DisclosureSEC source: 0001555280-18-000012 · wf-form4_151631305325731.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,773.4841 Underlying: Common Stock · 213.8447 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| October 13, 2017 Filed Oct 16, 2017 20:46 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 665.0403 | $20.82 | $13,846.14 |
DisclosureSEC source: 0001555280-17-000195 · wf-form4_150818679635636.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,097.5916 Underlying: Common Stock · 211.5853 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| July 14, 2017 Filed Jul 17, 2017 20:31 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 796.2808 | $20.19 | $16,076.91 |
DisclosureSEC source: 0001555280-17-000151 · wf-form4_150032346650101.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,432.5513 Underlying: Common Stock · 253.7792 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:31 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 4,973.0527 | $17.27 | $85,884.62 |
DisclosureSEC source: 0001555280-17-000111 · wf-form4_149281026941153.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,636.2705 Underlying: Common Stock · 1,594.8862 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:29 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 7,467.2281 | $17.10 | $127,689.60 |
DisclosureSEC source: 0001555280-17-000093 · wf-form4_149133774435928.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,663.2178 Underlying: Common Stock · 2,392.5351 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 04, 2017 Filed Mar 7, 2017 21:39 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 82,862.1812 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-17-000072 · wf-form4_148892278644052.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,957.0753 Underlying: Common Stock · 82,862.1812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 82,862.1812 RSUs vested on March 4, 2017; 41,130.2394 RSUs will vest on February 27, 2018; 50,600.8359 RSUs will vest on February 19, 2019; and 44,226 RSUs will vest on February 14, 2020. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 82,862.1812 RSUs vested on March 4, 2017; 41,130.2394 RSUs will vest on February 27, 2018; 50,600.8359 RSUs will vest on February 19, 2019; and 44,226 RSUs will vest on February 14, 2020. F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 82,862.1812 RSUs vested on March 4, 2017; 41,130.2394 RSUs will vest on February 27, 2018; 50,600.8359 RSUs will vest on February 19, 2019; and 44,226 RSUs will vest on February 14, 2020. Read SEC document |
| March 04, 2017 Filed Mar 7, 2017 21:39 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 42,052 | $53.42 | $2,246,417.84 |
DisclosureSEC source: 0001555280-17-000072 · wf-form4_148892278644052.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 Read SEC document |
| March 04, 2017 Filed Mar 7, 2017 21:39 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 82,862 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-17-000072 · wf-form4_148892278644052.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.